Nebraska recalls

Burlington Medical has recalled certain Blocker models because the Xenolite 800 material used in their construction may degrade over time, reducing how long the device will work properly. The recall affects units manufactured between January 16, 2025 and January 21, 2026. No injuries have been reported.

Burlington Medical Demi Half Aprons made with Xenolite 800 material between January 2025 and January 2026 may degrade over time, reducing how long they last. This affects 29 units sold worldwide. No injuries have been reported.

Burlington Medical half aprons manufactured between January 2025 and January 2026 with Xenolite 800 shielding material may degrade over time, reducing their protective effectiveness. This affects 30 different model numbers distributed worldwide. No injuries have been reported.

Burlington Medical leg wraps manufactured between January 2025 and January 2026 may experience material degradation over time, which could reduce how long the wraps last and their effectiveness. The issue affects specific models that used Xenolite 800 attenuation material. No injuries have been reported.

Burlington Medical issued a recall for certain radiation protection caps (models R8CAP, S8CAP, and U8CAP) manufactured between January 16, 2025 and January 21, 2026. The caps contain attenuation material that may degrade over time, which could reduce their ability to protect against radiation exposure.

Burlington Medical protective sleeves made with Xenolite 800 material may degrade over time, reducing how long they last. This affects sleeves manufactured between January 16, 2025 and January 21, 2026. No injuries have been reported.

Burlington Medical BAT (Breast, Axilla and Thyroid) radiation protective aprons made with Xenolite 800 material between January 2025 and January 2026 may lose their protective effectiveness over time. The material can degrade, reducing how well the apron shields against radiation.

Burlington Medical wrap aprons manufactured between January 16, 2025 and January 21, 2026 contain radiation-shielding material that degrades over time, reducing their protective effectiveness. This affects multiple model numbers across different sizes. No injuries have been reported.

Burlington Medical is recalling certain frontal aprons (radiation protection garments) with Xenolite 800 shielding material made between January 2025 and January 2026. The material may degrade over time, reducing its ability to protect against radiation exposure. No injuries have been reported.

Burlington Medical is recalling certain Kilt models because the Xenolite 800 attenuation material used in them may break down over time, reducing how long the product lasts. The recall affects units made between January 16, 2025 and January 21, 2026.

Burlington Medical protective vests made with Xenolite 800 attenuation material between January 16, 2025 and January 21, 2026 may weaken over time, reducing their protective lifespan. No injuries have been reported. The company is notifying users and working on a remedy.

Burlington Medical thyroid shields manufactured between January 16, 2025 and January 21, 2026 contain attenuation material that may degrade over time, reducing the shield's protective effectiveness. This affects multiple model numbers and sizes.

Medtronic MiniMed insulin pumps (Paradigm, 600, and 700 series) can deliver too much or too little insulin when the pump is held higher or lower than the infusion site on your body. This happens because gravity affects the pressure inside the pump tubing. Incorrect insulin doses can cause serious blood sugar problems.

Medtronic MiniMed insulin pumps (including Paradigm, 600, and 700 series models) may deliver too much or too little insulin when the pump is positioned above or below the infusion site. This happens because gravity affects how insulin flows through the tubing. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar.

Medtronic MiniMed insulin pumps (Paradigm, 600, and 700 series) can deliver too much or too little insulin depending on whether the pump is held above or below the infusion site. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar and other serious complications.

Medtronic MiniMed insulin pumps (Paradigm, 600, and 700 series) can deliver too much or too little insulin when the pump is held at different heights relative to the infusion site. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar and serious complications.

Medtronic MiniMed insulin pumps (Paradigm, 600, and 700 series) can deliver too much or too little insulin depending on whether the pump is positioned higher or lower than your infusion site. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar and other serious complications.

Medtronic MiniMed infusion pumps (Paradigm, 600, and 700 series) can deliver too much or too little insulin when the pump is raised or lowered relative to the infusion site. This happens because gravity affects pressure in the pump system. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar and serious complications.

Medtronic MiniMed insulin pumps (including 740G, Paradigm, 600, and 700 series) can deliver too much or too little insulin when the pump is positioned higher or lower than the infusion site on your body. This happens because gravity affects the pressure inside the pump tubing. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar.

Medtronic MiniMed insulin pumps (including MiniMed 720G, Paradigm, 600, and 700 series) can deliver too much or too little insulin depending on whether the pump is positioned above or below the infusion site. Too much insulin can cause dangerously low blood sugar, while too little can cause dangerously high blood sugar.

Medtronic MiniMed insulin pumps (including Paradigm, 600 series, and 700 series models) may deliver too much or too little insulin depending on whether the pump is held above or below the infusion site. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar and related complications.

Medtronic MiniMed insulin pumps (Paradigm, 600, and 700 series) can deliver too much or too little insulin when the pump height changes relative to the infusion site. When elevated, excess insulin may cause dangerously low blood sugar. When lowered, insufficient insulin may cause dangerously high blood sugar. This affects about 116,000 pumps worldwide.

Medtronic MiniMed insulin pumps may deliver too much or too little insulin depending on whether the pump is held above or below the infusion site on your body. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar. This happens because gravity affects how insulin flows through the pump.

Medtronic MiniMed insulin pumps (including the 780G model and older Paradigm and 600 series) may deliver too much or too little insulin when the pump is held higher or lower than the infusion site on your body. This happens because gravity affects how insulin flows through the tubing. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar.

Medtronic MiniMed insulin pumps (Paradigm, 600, and 700 series) can deliver too much or too little insulin when the pump is positioned higher or lower than your infusion site. This happens because gravity changes the pressure inside the pump. Too much insulin can cause dangerous low blood sugar; too little can cause dangerous high blood sugar and other complications.

Medtronic MiniMed insulin pumps can deliver too much or too little insulin when the pump is positioned higher or lower than the infusion site on your body. This happens because gravity affects the pressure inside the pump tubing. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar.

Medline's Anterior Hip Pack surgical kits contain Olympus biopsy valves that may shed rubber fragments. These fragments could lodge in a patient's airway during a procedure, potentially requiring removal and causing breathing problems or inflammation.

Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.

Medline kits containing Olympus biopsy valves may have rubber fragments that can detach inside the valve. These fragments could lodge in a patient's airways during a procedure, potentially requiring removal and causing inflammation or reduced oxygen levels.

Medline kits containing Olympus biopsy valves may have rubber fragments that can detach inside the valve. These fragments could enter a patient's airway and require removal, or cause inflammation and breathing problems. Olympus is investigating complaints about this issue.